Preliminary insights into artificial intelligence guided dosing in hypertension and diabetes: challenges and lessons learnt in a pilot feasibility study

This pilot demonstrates the feasibility of deploying CURATE.AI into outpatient care but underscores the importance of aligning data requirements with patient and clinical characteristics. Future studies should target newly diagnosed patient groups with greater dosing variability to optimise calibration and assess clinical utility.